IRIS
LAULETTA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 913
NA - Nord America 450
EU - Europa 365
SA - Sud America 108
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.855
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 425
SG - Singapore 354
RU - Federazione Russa 211
CN - Cina 203
VN - Vietnam 179
BR - Brasile 88
DE - Germania 53
HK - Hong Kong 46
IN - India 35
IT - Italia 34
JP - Giappone 30
KR - Corea 24
FR - Francia 22
BD - Bangladesh 11
MX - Messico 11
CA - Canada 10
AR - Argentina 9
ES - Italia 8
GB - Regno Unito 8
PH - Filippine 7
AT - Austria 5
EC - Ecuador 5
FI - Finlandia 5
NL - Olanda 5
TH - Thailandia 5
MA - Marocco 4
ZA - Sudafrica 4
CO - Colombia 3
DZ - Algeria 3
ID - Indonesia 3
IQ - Iraq 3
PL - Polonia 3
UA - Ucraina 3
CI - Costa d'Avorio 2
IE - Irlanda 2
LT - Lituania 2
PK - Pakistan 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GE - Georgia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
MR - Mauritania 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
SE - Svezia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
TZ - Tanzania 1
UZ - Uzbekistan 1
Totale 1.855
Salva come PNG Salva come JPEG
Città #
Singapore 190
San Jose 160
Hefei 90
Moscow 62
Ho Chi Minh City 58
Ashburn 50
Hanoi 44
Hong Kong 44
Beijing 40
Santa Clara 39
Tokyo 28
Kochi 18
Seoul 17
Lauterbourg 15
Los Angeles 13
Council Bluffs 12
Munich 12
Dallas 10
The Dalles 9
Nuremberg 8
Frankfurt am Main 7
Redondo Beach 7
Chennai 6
Haiphong 6
Mexico City 6
Naples 6
Rome 6
São Paulo 6
Schoenwalde 5
Turin 5
Vienna 5
Arezzo 4
Buffalo 4
Da Nang 4
Don Benito 4
Montreal 4
New York 4
Phủ Lý 4
Poplar 4
Atlanta 3
Biên Hòa 3
Falkenstein 3
Helsinki 3
Medellín 3
New Delhi 3
Quito 3
Rio de Janeiro 3
Salvador 3
Toronto 3
Amsterdam 2
Baghdad 2
Bengaluru 2
Boston 2
Brooklyn 2
Bình Dương 2
Bắc Giang 2
Calgary 2
Cape Town 2
Chicago 2
Curitiba 2
Denver 2
Dublin 2
Freiburg im Breisgau 2
Greensboro 2
Gwanak-gu 2
Houston 2
Jakarta 2
Philadelphia 2
Phoenix 2
Qingdao 2
Querétaro 2
Santa Rosa 2
Santo André 2
Thái Nguyên 2
Wroclaw 2
Xi'an 2
Aligarh 1
Americana 1
Amman 1
Amorosi 1
Annapolis 1
Araripina 1
Araruama 1
Araxá 1
Araçuaí 1
Atsugi 1
Aurangabad 1
Auriflama 1
Açailândia 1
Baguio City 1
Bagé 1
Bang Phli 1
Bangkok 1
Baoding 1
Barueri 1
Bauru 1
Belo Horizonte 1
Berazategui 1
Blida 1
Blumenau 1
Totale 1.124
Salva come PNG Salva come JPEG
Nome #
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 151
Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World Setting 137
Corrigendum: A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab (Clin Cosmet Investig Dermatol. (2023), 16, (3503–3507), 10.2147/CCID.S447123) 127
Management of Psoriasis Patients with Serious Infectious Diseases 123
Risk Factors for Psoriasis Flares: A Narrative Review 118
The Impact of Psoriasis Treatments on the Risk of Skin Cancer: A Narrative Review 115
Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluation 110
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials 107
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities 101
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond 99
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab 96
Effectiveness, Safety, and Long-Term Continuation Rate Analysis of Dupilumab Treatment in Adolescents with Atopic Dermatitis: A Single-Center Real-Life Retrospective Study 91
Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review 81
Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use 77
The emerging role of Bruton’s tyrosine kinase inhibition in urticaria management 69
The Use of JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Narrative Review of Clinical and Real-World Evidence 41
Efficacy and tolerability of bimekizumab within patients with moderate-to-severe plaque psoriasis: learnings from real world evidence 40
Biologics and small molecules for psoriasis: current and future progress 37
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study 22
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study 21
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study 21
Prevention and management of cutaneous immune‐related adverse events: EADV Task Force statement 20
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors 20
Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting—IL AD 20
Head and Neck Dermatitis in Atopic Dermatitis: A Narrative Review of Pathogenesis, Clinical Challenges, and Therapeutic Strategies 20
Letter: Atopic Dermatitis, 2-HEMA Allergic Contact Dermatitis, and Chemical Leukoderma: Which Relationship? 18
Totale 1.882
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.446
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202459 0 4 18 1 0 3 1 2 0 4 11 15
2024/2025512 11 20 3 18 16 39 34 43 27 59 189 53
2025/20261.311 112 133 108 127 195 58 144 149 190 95 0 0
Totale 1.882